These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A patient with acquired factor X deficiency and metastatic transitional cell carcinoma of the bladder: is there a link between metastasis and factor deficiency in solid tumors? Cammaert T; Decaestecker K; Sundahl N; Rottey S; Devreese KMJ Ann Hematol; 2018 Mar; 97(3):545-546. PubMed ID: 29130135 [No Abstract] [Full Text] [Related]
6. Stereotactic Body Radiation Therapy in the Management of Oligometastatic and Oligoprogressive Bladder Cancer and Other Urothelial Malignancies. Franzese C; Francolini G; Nicosia L; Alongi F; Livi L; Scorsetti M Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):50-56. PubMed ID: 32723486 [TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy for oligometastatic disease. Hanna GG; Landau D Clin Oncol (R Coll Radiol); 2015 May; 27(5):290-7. PubMed ID: 25770653 [TBL] [Abstract][Full Text] [Related]
9. Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe. Kroese TE; van Hillegersberg R; Schoppmann S; Deseyne PRAJ; Nafteux P; Obermannova R; Nordsmark M; Pfeiffer P; Hawkins MA; Smyth E; Markar S; Hanna GB; Cheong E; Chaudry A; Elme A; Adenis A; Piessen G; Gani C; Bruns CJ; Moehler M; Liakakos T; Reynolds J; Morganti A; Rosati R; Castoro C; D'Ugo D; Roviello F; Bencivenga M; de Manzoni G; Jeene P; van Sandick JW; Muijs C; Slingerland M; Nieuwenhuijzen G; Wijnhoven B; Beerepoot LV; Kolodziejczyk P; Polkowski WP; Alsina M; Pera M; Kanonnikoff TF; Nilsson M; Guckenberger M; Monig S; Wagner D; Wyrwicz L; Berbee M; Gockel I; Lordick F; Griffiths EA; Verheij M; van Rossum PSN; van Laarhoven HWM; Eur J Cancer; 2022 Mar; 164():18-29. PubMed ID: 35134666 [TBL] [Abstract][Full Text] [Related]
10. Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers. Huynh MA; Tang C; Siva S; Berlin A; Hannan R; Warner A; Koontz B; De Meeleer G; Palma D; Ost P; Tran PT Eur Urol Oncol; 2023 Feb; 6(1):28-38. PubMed ID: 36283936 [TBL] [Abstract][Full Text] [Related]
11. Bladder cancer. Br Med J (Clin Res Ed); 1981 Mar; 282(6269):1012-3. PubMed ID: 6783224 [No Abstract] [Full Text] [Related]
12. [How to treat infiltrating cancer of the bladder?]. Witjes JA; Debruyne FM Prog Urol; 1996 Apr; 6(2 Suppl 1):31-41. PubMed ID: 8704743 [No Abstract] [Full Text] [Related]
13. [Malignant mixed mesodermal tumor of the urogenital tract: report of a case developing in a patient with transitional cell carcinoma of the urinary bladder and discussion on its entity]. Fujita K; Nakauchi K; Matsumoto K Nihon Hinyokika Gakkai Zasshi; 1972 May; 63(5):346-52. PubMed ID: 4340680 [No Abstract] [Full Text] [Related]
14. Radiotherapy for the treatment of distant nodes metastases from oligometastatic urothelial cancer: A retrospective case series. Leonetti A; D'Abbiero N; Baldari G; Andreani S; Ruffini L; Viansone AA; Buti S Int J Urol; 2018 Oct; 25(10):879-886. PubMed ID: 30103254 [TBL] [Abstract][Full Text] [Related]
15. Patterns of recurrence in bladder cancer treated by irradiation and/or cystectomy. Batata MA; Whitmore WF; Chu FC; Hilaris BS; Unal A; Chung S Int J Radiat Oncol Biol Phys; 1980 Feb; 6(2):155-9. PubMed ID: 7390890 [No Abstract] [Full Text] [Related]
16. [Treatment of advanced cancer of the bladder]. Fosså SD; Miller A Tidsskr Nor Laegeforen; 1975 May; 95(13):809-11. PubMed ID: 49090 [No Abstract] [Full Text] [Related]